Relacore

Relacore Extra

Serving
3 Tablet(s)
Per container
30
Form
tablet
UPC
681168178079
DSLD
Formula hash
6855bfe2ad21
Brand context
Catalog
4
products
With avoid flag
4
products
FDA recalls
0
history
CAERS
24
reports
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
3
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

13 active ingredients
IngredientAmount% DV
Vitamin C
vitaminUNII · PQ6CK8PD0R
UL · set5 effects
1000 mg1667%
Calcium
mineralUNII · SY7Q814VUP
UL · set6 effects
100 mg10%
Thiamine
ThiaminvitaminUNII · X66NSO3N35
3 effects
15 mg1000%
Riboflavin
vitaminUNII · TLM2976OFR
5 effects
15 mg882%
Niacin
vitaminUNII · 2679MF687A
3 effects
1.4× ULexceeds NIH ODS adult upper limitsource →
50 mg250%
Vitamin B6
vitaminUNII · KV2JZ1BI6Z
UL · set6 effects
10 mg500%
Folate
vitaminUNII · 935E97BOY8
UL · set2 effects
400 mcg100%
Vitamin B12
vitaminUNII · 8406EY2OQA
3 effects
10 mcg167%
Biotin
vitaminUNII · 6SO6U10H04
3 effects
150 mcg50%
Pantothenic Acid
Pantothenic Acid (Vitamin B5)vitaminUNII · 19F5HK2737
23 mg230%
Magnesium
mineralUNII · I38ZP9992A
UL · set6 effects
100 mg25%
Zinc
mineralUNII · J41CSQ7QDS
UL · set8 effects
10 mg67%
Relacortin(R) Plus
Proprietary Blend (Combination)other
240 mg
What this product supports · authorized claims

22 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Red 40 Lake
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

  • ◐ CAUTIONFD&C Blue 1 {Lake}
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

  • ◐ CAUTIONFD&C Yellow 5 Lake
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

FDA CAERS · adverse event context
3
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Stearic Acid · Croscarmellose Sodium · Silicon Dioxide · Polyvinyl Alcohol · Talc · Polyethylene Glycol · Polysorbate 80 · {FD&C Blue} 2 Lake